1mdata.com

About 1mdata.com

Beijing Yiming Technology Co., Ltd., operating as 1mdata.com, is a medical data company established in July 2015 by founder Ma Min. Drawing from over a decade of experience in sales and management roles at major pharmaceutical companies like Pfizer and Novartis, Ma Min identified significant pain points for doctors in China related to the burdensome and time-consuming nature of managing medical documentation for clinical and research purposes. The company was founded to address these challenges by structuring and analyzing electronic medical record-related documents, aiming to alleviate the workload for physicians.

The company's core business revolves around providing comprehensive data services to medical institutions, including data interconnection, standardization, and mining. Its business model focuses on offering big data analysis and solutions to these institutions. The target market includes hospitals, pharmaceutical and medical device companies, and clinical research organizations that require high-quality, real-world clinical data. 1mdata has developed a suite of hardware and software products to achieve its objectives. This includes the "Yiming Data Collection System," which connects with various internal hospital systems (like HIS, EMR, and LIS) to automatically gather patient information, and the "Yiming Data Intelligent Processing System," which uses natural language processing and neural networks to structure and clean the collected data with high accuracy. The platform is designed to support physicians in their clinical research and patient management needs.

Since its inception, 1mdata has secured significant funding to fuel its growth. It initially raised several million RMB in an angel round from Fenghou Capital and a nearly ten million RMB pre-A round led by Western Capital. This was followed by a Series A round in September 2016, a nearly 100 million RMB Series B in November 2017 led by Guozhong Capital, and a Series B+ round in October 2018. By 2017, the company's solutions had been implemented in over 300 hospitals across China and it had formed partnerships with key institutions like the National Health and Family Planning Commission.